Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I studyJianliang Yang, Yuankai Shi, Xiaohong Han et al.|European Journal of Cancer|2020Cited by 70
Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variantNana Zhang, Cheng‐Feng Qin, Rongrong Zhang et al.|Cell Research|2022Cited by 60
Expression and Characterization of a Potent Long-Acting GLP-1 Receptor Agonist, GLP-1-IgG2σ-FcYi Yang, Haifeng Song, Fang Chen et al.|PLoS ONE|2016Cited by 8
ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calvesRineke de Jong, Ann‐Muriel Steff, Norbert Stockhofe-Zurwieden et al.|Research Square|2021Cited by 5
A phase 1 trial of JS001, a monoclonal antibody targeting programmed death-1 (PD-1) in patients with advanced or recurrent malignancies.Sheng Yang, Yuankai Shi, Jianliang Yang et al.|Journal of Clinical Oncology|2017Cited by 2